Temporal Reframing of Tumours: A Multidimensional Pathway Toward Immune Awakening and Therapeutic Breakthrough

Temporal Reframing of Tumours: A Multidimensional Pathway Toward Immune Awakening and Therapeutic Breakthrough | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Temporal Reframing of Tumours: A Multidimensional Pathway Toward Immune Awakening and Therapeutic Breakthrough Theodor-Nicolae Carp This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7520575/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background: Tumor biology is driven not only by genetic and epigenetic alterations but also by disruptions in circadian timing, immune rhythms, and tissue-level dynamics. Cancer often exploits temporal disarray to evade apoptosis and immune detection, yet time-based vulnerabilities remain underutilized in therapy. Objective: This paper introduces a relativistic, cross-disciplinary framework in which cancer is conceptualized as a temporally misaligned system. The aim is to translate theoretical constructs into experimentally testable strategies for chrono-immunotherapy. Methods: Three interlocking hypotheses are proposed: (i) Localized Emotion Generation (LEG) , the failure of tumors to produce coherent immune-signaling cues; (ii) Circadian Illusion Engineering (CIE) , the induction of localized “death zones” through phase inversion of rhythmic signals; and (iii) the Hurricane Eye Model (HEM) , which describes the hypoxic tumor core as a rhythm-free sanctuary requiring targeted disruption. These are unified under a Relativistic Compartmental Model (RCM) that treats cancer as a compartment existing in accelerated biological time. Results: Evidence from chronobiology, immunology, and pharmacology supports this approach. Clock gene disruption (PER2, BMAL1) accelerates tumorigenesis; selective serotonin reuptake inhibitors (SSRIs) induce apoptosis and recalibrate T-cell energetics; interferon-β pacing improves viral immunogenicity and tumor clearance. Each hypothesis is aligned with measurable biomarkers (PER2::Luc oscillations, cytokine gradients, hypoxic markers) and tractable experimental systems (organoids, hypoxic spheroids, murine models). Conclusion: This relativistic-chronobiological framework proposes testable strategies that reconceptualize cancer not as an invader to be eliminated but as a temporal anomaly to be re-synchronized. In this vision, therapeutic interventions may act as “micro-time machines,” locally restoring coherence by shifting cellular and tissue rhythms back into systemic alignment. This framework likewise integrates biomedical evidence with broader conceptual insights, offering a vision of oncology grounded in coherence, transformation, and systemic realignment. Oncology Molecular Biology Immunology Biophysics Chronotherapy Circadian Disruption Cancer Relativity Tumour Semiotics Immune Re-entrainment Circadian Disruption Oncolytic Virotherapy SSRIs in Oncology Metabolic Reprogramming Tumour Microenvironment Temporal Therapeutics Warburg Effect Biophysics of Cancer Philosophical Bioethics Full Text Additional Declarations The authors declare no competing interests. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7520575","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":509282178,"identity":"2619e129-bc51-47e8-b2d0-fd08e0cb1685","order_by":0,"name":"Theodor-Nicolae Carp","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABLUlEQVRIiWNgGAWjYDACCSDmAbMYG5gZGCwYGJgZGw58APLZ2LHr4EHTAuSyMx98OAOkhZmgFqD5YC38bMnGPFAuNmAv3XzwwZuKe3IM0s2NnwsqJOTlm3nMpG1+bZPnY2Zg/PAxB9MWmWPJhnPOFBszyBxslp5xRsJww2Gglty+24ZtzAzMkjO3YXFYjpk0b1tCYoNEYhszb5sE4wZmkJae24xALWzMvNi05H8DaamHabGfD3KYZc9te9xacthAWhIYoFoSGw4Dvc/w43YiTi030oyBfkkwBCpuluY5I5G84TAwkHsbbie3MTM2Y/ML+4zkh8AQS5Dnl0h/+JmnwsZ2fv/BhgM//ty2nd/efPDDR0wtcMCGwmNsA5MNuNVjgj+kKB4Fo2AUjIJhDgDplWFBM9yRDgAAAABJRU5ErkJggg==","orcid":"https://orcid.org/0000-0002-9237-8099","institution":"University of Westminster","correspondingAuthor":true,"prefix":"","firstName":"Theodor-Nicolae","middleName":"","lastName":"Carp","suffix":""}],"badges":[],"createdAt":"2025-09-02 19:07:27","currentVersionCode":1,"declarations":{"humanSubjects":false,"vertebrateSubjects":false,"conflictsOfInterestStatement":false,"humanSubjectEthicalGuidelines":false,"humanSubjectConsent":false,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-7520575/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7520575/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":90554251,"identity":"fe860957-5cf2-45ec-8e21-c3a0a1220256","added_by":"auto","created_at":"2025-09-04 04:05:36","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":387379,"visible":true,"origin":"","legend":"","description":"","filename":"TemporalReframingofTumoursAMultidimensionalPathwayTowardImmuneAwakeningandTherapeuticBreakthrough.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7520575/v1_covered_cb52faa0-9f9a-4042-a769-66d14cac3c5f.pdf"}],"financialInterests":"The authors declare no competing interests.","formattedTitle":"\u003cp\u003eTemporal Reframing of Tumours: A Multidimensional Pathway Toward Immune Awakening and Therapeutic Breakthrough\u003c/p\u003e","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"Affiliation: Independent Researcher","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":true,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Chronotherapy, Circadian Disruption, Cancer Relativity, Tumour Semiotics, Immune Re-entrainment, Circadian Disruption, Oncolytic Virotherapy, SSRIs in Oncology, Metabolic Reprogramming, Tumour Microenvironment, Temporal Therapeutics, Warburg Effect, Biophysics of Cancer, Philosophical Bioethics","lastPublishedDoi":"10.21203/rs.3.rs-7520575/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7520575/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground:\u003c/strong\u003e Tumor biology is driven not only by genetic and epigenetic alterations but also by disruptions in circadian timing, immune rhythms, and tissue-level dynamics. Cancer often exploits temporal disarray to evade apoptosis and immune detection, yet time-based vulnerabilities remain underutilized in therapy.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eObjective:\u003c/strong\u003e This paper introduces a relativistic, cross-disciplinary framework in which cancer is conceptualized as a temporally misaligned system. The aim is to translate theoretical constructs into experimentally testable strategies for chrono-immunotherapy.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods:\u003c/strong\u003e Three interlocking hypotheses are proposed: (i) \u003cem\u003eLocalized Emotion Generation (LEG)\u003c/em\u003e, the failure of tumors to produce coherent immune-signaling cues; (ii) \u003cem\u003eCircadian Illusion Engineering (CIE)\u003c/em\u003e, the induction of localized “death zones” through phase inversion of rhythmic signals; and (iii) the \u003cem\u003eHurricane Eye Model (HEM)\u003c/em\u003e, which describes the hypoxic tumor core as a rhythm-free sanctuary requiring targeted disruption. These are unified under a \u003cem\u003eRelativistic Compartmental Model (RCM)\u003c/em\u003e that treats cancer as a compartment existing in accelerated biological time.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults:\u003c/strong\u003e Evidence from chronobiology, immunology, and pharmacology supports this approach. Clock gene disruption (PER2, BMAL1) accelerates tumorigenesis; selective serotonin reuptake inhibitors (SSRIs) induce apoptosis and recalibrate T-cell energetics; interferon-β pacing improves viral immunogenicity and tumor clearance. Each hypothesis is aligned with measurable biomarkers (PER2::Luc oscillations, cytokine gradients, hypoxic markers) and tractable experimental systems (organoids, hypoxic spheroids, murine models).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion:\u003c/strong\u003e This relativistic-chronobiological framework proposes testable strategies that reconceptualize cancer not as an invader to be eliminated but as a temporal anomaly to be re-synchronized. In this vision, therapeutic interventions may act as “micro-time machines,” locally restoring coherence by shifting cellular and tissue rhythms back into systemic alignment. This framework likewise integrates biomedical evidence with broader conceptual insights, offering a vision of oncology grounded in coherence, transformation, and systemic realignment.\u003c/p\u003e","manuscriptTitle":"Temporal Reframing of Tumours: A Multidimensional Pathway Toward Immune Awakening and Therapeutic Breakthrough","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-09-04 03:57:10","doi":"10.21203/rs.3.rs-7520575/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"d1ddc9b8-f630-4085-ba87-1d092978f03c","owner":[],"postedDate":"September 4th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":54090780,"name":"Oncology"},{"id":54090781,"name":"Molecular Biology"},{"id":54090782,"name":"Immunology"},{"id":54090783,"name":"Biophysics"}],"tags":[],"updatedAt":"2025-09-04T03:57:10+00:00","versionOfRecord":[],"versionCreatedAt":"2025-09-04 03:57:10","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-7520575","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7520575","identity":"rs-7520575","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}